← Back to Search

Time-lapse enabled embryo test

Day 3 eSET combined with Eeva for Infertility (PPS Trial)

N/A
Waitlist Available
Research Sponsored by Progyny, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8-12 week gestation
Awards & highlights

PPS Trial Summary

The purpose of this clinical investigation is to gather pilot data to evaluate the impact of using Eeva™, a time-lapse enabled embryo test, in combination with traditional morphology on clinical pregnancy rates.

PPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8-12 week gestation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-12 week gestation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Pregnancy
Secondary outcome measures
Ongoing pregnancy rate

PPS Trial Design

3Treatment groups
Active Control
Group I: Day 3 eSET combined with EevaActive Control1 Intervention
Traditional Morphology + Eeva™ results
Group II: Day 5 eSET with Traditonal MorphologyActive Control1 Intervention
Group III: Day 5 eSET combined with EevaActive Control1 Intervention
Traditional Morphology + Eeva™ results

Find a Location

Who is running the clinical trial?

Progyny, Inc.Lead Sponsor
9 Previous Clinical Trials
2,272 Total Patients Enrolled
9 Trials studying Infertility
2,272 Patients Enrolled for Infertility

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~22 spots leftby Apr 2025